Rosiglitazone

Avandia

2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** tabletVereinigte StaatenNicht im HandelZugelassen am 25. Mai 1999